ODONTOPREV (ODPV3) Main Indicators
Relative Prices, Market Cap, EV, and Dividend Yield | |
|---|
| Price/Earnings | 10.70 |
| Price/SBV | 4.70 |
| Price/Net Sales | 2.53 |
| Price/CFO | 9.54 |
| Price/FCF | 9.70 |
| Price/Total Assets | 2.72 |
| Price/EBIT | 8.40 |
| Price/Working Capital | -21.01 |
| Price/NCAV | -4.94 |
| EV/EBIT | 8.37 |
| EV/EBITDA | 7.81 |
| EV/Net Sales | 2.52 |
| EV/CFO | 9.51 |
| EV/FCF | 9.68 |
| EV/Total Assets | 2.71 |
| Company Market Cap | R$ 5.77 B |
| Enterprise Value | R$ 5.75 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 10.57 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 14.11% |
Summary Income Statement Last 12 Months | |
|---|
| Net Revenue | R$ 2.28 B |
| Gross Result | R$ 783.05 M |
| EBIT | R$ 687.23 M |
| Depreciation and Amortization | - R$ 49.79 M |
| EBITDA | R$ 737.03 M |
| Net Profit | R$ 539.24 M |
| Net Profit/Share | R$ 0.98 |
Summary Income Statement Last Quarter | |
|---|
| Net Revenue | R$ 585.97 M |
| Gross Result | R$ 174.36 M |
| EBIT | R$ 148.31 M |
| Depreciation and Amortization | - R$ 13.96 M |
| EBITDA | R$ 162.27 M |
| Net Profit | R$ 114.65 M |
| Profit/Share | R$ 0.21 |
Stock Price and Stock Volume Behavior| Lowest Price 52 weeks | R$ 9.95 |
| Highest Price 52 weeks | R$ 11.87 |
| Variation 2025 | -0.34% |
| Variation 1 year | -1.42% |
| Variation 2 years(total) | 12.85% |
| Variation 2 years(yearly) | 6.21% |
| Variation 3 years(total) | 12.77% |
| Variation 3 years(yearly) | 4.08% |
| Variation 4 years(total) | 10.03% |
| Variation 4 years(yearly) | 2.42% |
| Variation 5 years(total) | 2.81% |
| Variation 5 years(yearly) | 0.56% |
| Average Daily Volume (3 months) | R$ 10.67 M |
| Updated 04/02/2025 |
Returns, Margins, and Other Measures | |
|---|
| Return on Initial Tangible Capital | 72.97% |
| Return on Initial Invested Capital | 33.04% |
| Pre-Tax Return on Initial Tangible Capital | 110.56% |
| Pre-Tax Return on Initial Invested Capital | 50.07% |
| Return on Initial Shareholder´s Equity | 38.88% |
| Return on Initial Asset | 24.92% |
| Gross Margin | 34.33% |
| Net Margin | 23.64% |
| EBIT Margin | 30.13% |
| EBITDA Margin | 32.31% |
| Initial Asset Turnover | 1.05 |
| Financial Leverage | 1.73 |
| Liabilities/Net Worth | 0.73 |
| Net Debt/EBITDA | -0.02 |
Summary Balance Sheet | |
|---|
| Cash and Cash Equivalents | R$ 16.53 M |
| Total Assets | R$ 2.12 B |
| Short-Term Debt | R$ 0.00 |
| Long-Term Debt | R$ 0.00 |
| Gross Debt | R$ 0.00 |
| Net Debt | - R$ 16.53 M |
| Shareholder´s Equity | R$ 1.23 B |
| Share Book Value | R$ 2.22 |
| Common Shares | 552,495,663 |
| Preferred Shares | 0 |
| Total | 552,495,663 |
| Common Shares in Treasury | 6,188,777 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 6,188,777 |
| Common Shares (Except Treasury) | 546,306,886 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 546,306,886 |
Summary Cash Flow Statement Last 12 Months | |
|---|
| Operating Cash Flow | R$ 604.99 M |
| Cash Flow from Investments | R$ 9.06 M |
| Financing Cash Flow | - R$ 611.91 M |
| Increase (Reduction) in Cash and Equivalents | R$ 2.14 M |
Summary Cash Flow Statement Last Quarter | |
|---|
| Operating Cash Flow | R$ 354.07 M |
| Cash Flow from Investments | - R$ 37.84 M |
| Financing Cash Flow | - R$ 309.74 M |
| Increase (Reduction) in Cash and Equivalents | R$ 6.49 M |
Experimental CAPEX and Free Cash Flow Calculation | |
|---|
| CAPEX 3 months | - R$ 2.00 M |
| Free Cash Flow 3 months | R$ 352.07 M |
| CAPEX 12 months | - R$ 10.38 M |
| Free Cash Flow 12 months | R$ 594.60 M |